The federal lawsuit against Hims & Hers exposes the dangerous friction between rapid telehealth growth and basic consumer privacy.

Telehealth platforms sell convenience. But a joint lawsuit by the Federal Trade Commission, California, and Utah suggests that convenience comes with a hidden cost: your most intimate medical data.

Regulators allege that Hims & Hers shared highly sensitive user data with social media advertisers. This included information about erectile dysfunction and hair loss. They also allege the company trapped users in deceptive, hard-to-cancel subscriptions.

The Privacy Illusion

Patients assume digital clinics operate under the same strict privacy rules as traditional doctor offices. They do not.

By treating health data as marketing fuel, direct-to-consumer platforms treat patients as products. Hims & Hers dismissed the allegations as “baseless” and accused regulators of trying to generate headlines.

Yet the market reacted instantly. The company’s stock plummeted over 11% following the announcement.

A Regulatory Shift

This is not an isolated case. It is a pattern.

The FTC is systematically targeting digital health platforms that leak data to ad networks. For the industry, the message is clear.

The era of “move fast and break things” in healthcare is over. Startups can no longer fund cheap customer acquisition by quietly monetizing patient trust. If the FTC succeeds, it will force a complete rewrite of the digital health business model.